Argenx
Clinical trials sponsored by Argenx, explained in plain language.
-
New drug hope for brain inflammation patients
Disease control Not yet recruitingThis study tests a drug called efgartigimod for people with autoimmune encephalitis, a condition where the immune system attacks the brain. About 170 adults and teens will receive either the drug or a placebo to see if it improves symptoms like memory loss, seizures, and weakness…
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New hope for Graves' patients: drug aims to restore normal thyroid function
Disease control Not yet recruitingThis study tests an investigational drug called efgartigimod in 230 adults with Graves' disease whose thyroid levels are still too high despite taking standard antithyroid drugs. The goal is to see if efgartigimod can help bring thyroid hormones back to normal and allow patients …
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New hope for Graves' patients: drug aims to tame thyroid when standard pills fail
Disease control Not yet recruitingThis study tests an investigational drug called efgartigimod in adults with Graves' disease whose thyroid levels are still too high despite taking antithyroid drugs. The goal is to see if adding efgartigimod can help bring thyroid hormones back to normal and allow patients to red…
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated May 18, 2026 12:11 UTC